Login / Signup

Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer.

Xing GaoOsbert Qi-Yao LeowChien-Hung ChiuMing-Mo HouJason Chia-Hsun HsiehYin Kai Chao
Published in: Journal of personalized medicine (2022)
CTCs count assessed in combination with CRE can potentially help identify patients with EC who achieved MaHR after nCRT.
Keyphrases
  • circulating tumor cells
  • rectal cancer
  • locally advanced
  • circulating tumor
  • squamous cell carcinoma
  • lymph node
  • radiation therapy
  • peripheral blood